Works matching IS 17588340 AND DT 2022 AND VI 14

Results: 4
    1
    2

    Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, v. 14, p. 1, doi. 10.1177/17588359221141760
    By:
    • Oliveira, Leandro Jonata Carvalho;
    • Megid, Thais Baccili Cury;
    • Rosa, Daniela Dornelles;
    • Magliano, Carlos Alberto da Silva;
    • Assad, Daniele Xavier;
    • Argolo, Daniel Fontes;
    • Sanches, Solange Moraes;
    • Testa, Laura;
    • Bines, José;
    • Kaliks, Rafael;
    • Caleffi, Maira;
    • de Melo Gagliato, Debora;
    • Sahade, Marina;
    • Barroso-Sousa, Romualdo;
    • Corrêa, Tatiana Strava;
    • Shimada, Andrea Kazumi;
    • Batista, Daniel Negrini;
    • Musse Gomes, Daniel;
    • Cesca, Marcelle Goldner;
    • Gaudêncio, Débora
    Publication type:
    Article
    3
    4

    Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, v. 14, p. 1, doi. 10.1177/17588359221141307
    By:
    • de Rauglaudre, Bernadette;
    • Sibertin-Blanc, Camille;
    • Fabre, Aurélie;
    • Le Malicot, Karine;
    • Bennouna, Jaafar;
    • Ghiringhelli, François;
    • Taïeb, Julien;
    • Boige, Valérie;
    • Bouché, Olivier;
    • Chatellier, Thierry;
    • Faroux, Roger;
    • François, Eric;
    • Jacquot, Stéphane;
    • Genet, Dominique;
    • Mulot, Claire;
    • Olschwang, Sylviane;
    • Seitz, Jean-François;
    • Aparicio, Thomas;
    • Dahan, Laetitia
    Publication type:
    Article